The importance of predictive biomarkers in oncology drug development

被引：11

作者：

Jorgensen, Jan Trost ^{[1
]}

机构：

[1] Dx Rx Inst, Baunevaenget 76, DK-3480 Fredensborg, Denmark

来源：

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS | 2016年 / 16卷 / 08期

关键词：

Companion diagnostics; complementary diagnostics; personalized medicine; precision medicine; NSCLC; crizotinib; ceritinib; alectinib; ROS1; ALK; CELL LUNG-CANCER; CRIZOTINIB; RISK;

D O I：

10.1080/14737159.2016.1199962

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：807 / 809

页数：3

共 11 条

[1] Second-line combination therapies in nonsmall cell lung cancer without known driver mutations [J].

Bluthgen, Maria-Virginia ;

Besse, Benjamin .

EUROPEAN RESPIRATORY REVIEW, 2015, 24 (138) :582-593

[2] Biomarkers and Receptor Targeted Therapies Reduce Clinical Trial Risk in Non-Small-Cell Lung Cancer [J].

Falconi, Adam ;

Lopes, Gilberto ;

Parker, Jayson L. .

JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (02) :163-169

[3] Crizotinib for ALK-Rearranged Non-Small Cell Lung Cancer: A New Targeted Therapy for a New Target [J].

Gandhi, Leena ;

Jaenne, Pasi A. .

CLINICAL CANCER RESEARCH, 2012, 18 (14) :3737-3742

[4] Clinical application of companion diagnostics [J].

Jorgensen, Jan Trost .

TRENDS IN MOLECULAR MEDICINE, 2015, 21 (07) :405-407

[5] Where is personalized medicine in industry heading? [J].

Milne, Christopher-Paul ;

Cohen, Joshua P. ;

Chakravarthy, Ranjana .

NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (12) :812-813

[6]

Molecular Abbott, 2011, VYS ALK BREAK AP FIS

[7]

Pfizer, U S PRESCR INF XALK

[8] Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer [J].

Rikova, Klarisa ;

Guo, Ailan ;

Zeng, Qingfu ;

Possemato, Anthony ;

Yu, Jian ;

Haack, Herbert ;

Nardone, Julie ;

Lee, Kimberly ;

Reeves, Cynthia ;

Li, Yu ;

Hu, Yerong ;

Tan, Zhiping ;

Stokes, Matthew ;

Sullivan, Laura ;

Mitchell, Jeffrey ;

Wetzel, Randy ;

MacNeill, Joan ;

Ren, Jian Min ;

Yuan, Jin ;

Bakalarski, Corey E. ;

Villen, Judit ;

Kornhauser, Jon M. ;

Smith, Bradley ;

Li, Daiqiang ;

Zhou, Xinmin ;

Gygi, Steven P. ;

Gu, Ting-Lei ;

Polakiewicz, Roberto D. ;

Rush, John ;

Comb, Michael J. .

CELL, 2007, 131 (06) :1190-1203

[9]

Rubinger DA, 2015, BIOMARK MED, V9, P13, DOI [10.2217/bmm.14.80, 10.2217/BMM.14.80]

[10] Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancer [J].

Shaw, Alice T. ;

Ou, Sai-Hong I. ;

Bang, Yung-Jue ;

Camidge, D. Ross ;

Solomon, Benjamin J. ;

Salgia, Ravi ;

Riely, Gregory J. ;

Varella-Garcia, Marileila ;

Shapiro, Geoffrey I. ;

Costa, Daniel B. ;

Doebele, Robert C. ;

Long Phi Le ;

Zheng, Zongli ;

Tan, Weiwei ;

Stephenson, Patricia ;

Shreeve, S. Martin ;

Tye, Lesley M. ;

Christensen, James G. ;

Wilner, Keith D. ;

Clark, Jeffrey W. ;

Iafrate, A. John .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (21) :1963-1971

← 1 2 →